Fund Card

Fund Card

Tata India Pharma & Healthcare Fund-Reg(G)

As on Mar-05-2021 change fund
14.55  down-0.22 (-1.49%)

fund objective

Investment objective of the scheme is to provide long term capital appreciation by investing predominantly in equity/equity related instruments of the companies in the Pharma&Healthcare sectors in India. However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2016-20172017-20182018-20192019-20202020-2021
NAV in Rs (as on 04-Mar-2021)9.118.359.098.9314.77
Net Assets(Rs Crores) (as on 04-Mar-2021) 80.88 133.13 179.56 152.64 408.24
Scheme Returns(%)(Absolute)-2.87-9.687.51-2.1967.77
B'mark Returns(%)(Absolute)-4.73-20.438.42-23.4575.78
Category Rank52/5654/6224/7311/7553/75
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2020-202125.0721.7811.24NA
2019-2020-4.661.784.39-2.98
2018-20192.446.80-4.444.15
2017-2018-4.38-6.159.58-6.86
2016-2017-0.321.99-10.176.42
Top 10 holdings
company (%)
Dr. Reddys Laboratories Ltd.12.13 
Sun Pharmaceutical Industries...9.91 
Cipla Ltd.9.31 
Divis Laboratories Ltd.7.64 
Narayana Hrudayalaya Ltd.7.17 
Alkem Laboratories Ltd.6.57 
Ipca Laboratories Ltd.5.69 
Lupin Ltd.5.01 
Procter & Gamble Health Ltd.4.53 
Apollo Hospitals Enterprise Ltd.4.42 

Category

Sector Funds

Launch Date

28-Dec-15

Scheme Benchmark

NA

AUM ( in Cr.)

408.24

portfolio price to book value

6.22

investing style?

Large Growth

fund manager?

Meeta Shetty,Rahul Singh (Tata)

inception date (regular plan)

28-Dec-15

expense ratio (regular plan) %

2.64

Alpha [%]

0.11

Beta [%]

0.45

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs75.78
Hospital & Healthcare Services14.28
Miscellaneous5.20

Historical NAV Chart with Benchmark

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes
scheme name investment style inception date AUM in Cr. 1W(%) 1M(%) 3M(%) 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015408.241.72-1.991.8849.7319.298.37NA7.81BUYSIP
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20044,197.032.65-1.093.2657.0321.4212.8617.2821.24BUYSIP
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19991,551.451.22-1.673.6852.7816.687.4516.9015.63BUYSIP
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005617.191.91-1.181.4755.3916.679.1913.9718.39BUYSIP
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20182,010.141.91-0.512.6362.38NANANA23.76BUYSIP
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20181,048.741.13-1.053.1958.16NANANA33.69BUYSIP
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20181,166.012.150.513.3657.80NANANA26.78BUYSIP
IDBI Healthcare Fund-Reg(G)Large-Growth 28-Feb-201965.021.61-0.670.6145.86NANANA27.77BUYSIP
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019441.971.70-1.411.9041.49NANANA33.56BUYSIP

Copyright © 2017 Vedant Asset. All Right Reserved.

Mutual Fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not an indicator of future returns. ARN-104974